⌕
Lilly(Eli) · LLY · NYSE
Tenet 49 · Mixed
Compare
$1,415.55−1.13%At closeTenet 49 · Mixed
$1,415.55−16.12 (−1.13%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
$1,400.12−15.43 (−1.09%)
After hours: Nov 17, 2026, 7:58 PM ET

Lilly(Eli) (LLY) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~23.2%/yr (FY21→FY25), net margin 31.7%; free cash flow runs at 43% of net income. Check the accrual gap. Worth your attention in FY25: Capex step-up ($7.8B) and Returns vs FCF (106%). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($B)▲44.7%
65.2
FY21→FY25CAGR +23.2%/yr
Net income ($B)▲94.9%
20.6
one-off year: see footnoteCAGR +38.7%/yr
Free cash flow ($B)▲138.6%
9.0
capex stepped upCAGR +10.3%/yr
Diluted EPS▲96.0%
22.95
FY21→FY25CAGR +39.2%/yr
What the receipts whisper · what a headline number hides
Share count
−1.4%

911.7mn → 899.3mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex step-up
$7.8B

▲55% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

Returns vs FCF
106%

$9.5B returned vs $9.0B of FCF in FY25. The gap comes off the balance sheet (see net cash).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($B)65.2Revenue−11.1COGS54.1Gross profit−16.2R&D−11.1SG&A26.3Op income−5.7Tax & other20.6Net income

32¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
906845230%sector median net margin ~3%FY21FY25

Over this window: gross 74.2% → 83.0%. Net margin 31.7% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
86,461.065,179.045,043.034,124.028,541.428,318.4▲44.7%+23.2%
Cost of revenue
14,149.011,052.08,418.07,082.06,629.87,312.8▲31.3%+10.9%
Gross profit
72,312.054,127.036,625.027,042.021,911.621,005.6▲47.8%+26.7%
Research & development
23,446.016,247.014,271.013,113.08,099.37,900.8▲13.8%+19.8%
Selling, general & admin
12,621.011,094.08,594.07,404.06,440.46,431.6▲29.1%+14.6%
Total operating expenses
37,436.027,825.023,726.020,585.014,784.314,648.5▲17.3%+17.4%
Operating incomefeeds ROC rank
34,876.026,302.012,899.06,457.07,127.36,357.1▲103.9%+42.6%
Other income, net
−108.0−571.0−219.097.0−320.9−201.6——
Pretax income
34,768.025,731.012,680.06,554.06,806.46,155.5▲102.9%+43.0%
Income tax
7,189.05,091.02,090.01,314.0561.6573.8▲143.6%+72.6%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
27,579.020,640.010,590.05,240.06,244.85,581.7▲94.9%+38.7%
Per share
Diluted EPSbuyback-sensitive
30.8122.9511.715.806.906.12▲96.0%+39.2%
Diluted shares (mn)
893.40899.30904.10903.30904.62911.68▼0.5%−0.3%
Margins
Gross margin78th pct in Healthcare
83.6%83.0%81.3%79.2%76.8%74.2%▲1.7pp+8.9pp
Operating margin
40.3%40.4%28.6%18.9%25.0%22.4%▲11.7pp+17.9pp
Net margin95th pct in Healthcare
31.9%31.7%23.5%15.4%21.9%19.7%▲8.2pp+12.0pp
† TTM = trailing four quarters through 2026-09-30.FY22 effective tax rate was 8% vs a 16% norm for this window, likely a one-time item; see the filing.
FY07 – FY20 · 14 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-12 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Lilly(Eli)'s revenue last fiscal year?

Lilly(Eli) reported revenue of $65.2B in fiscal 2025, up 44.7% from fiscal 2024.

What was Lilly(Eli)'s net income?

Lilly(Eli) reported net income of $20.6B in fiscal 2025, a net margin of 31.7%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.